In subjects with DM, the use of GLP-1 RA is associated with a significant reduction of glycated hemoglobin, with weight loss, a modest decrease in blood pressure, and an improvement of hyperlipidemia (75, 76). The gene discussed is GLP1R; the disease is diabetes mellitus.